Patent Situation of The Key Product for Treatment of Hepatitis C: DACLASTAVIR – WHO working paper, revised version, Oct 2014

Patent Situation of The Key Product for Treatment of Hepatitis C: DACLASTAVIR – WHO working paper, revised version, Oct 2014

WHO working paper to identify relevant patents for Daclatasvir and providing data where these patents have been filed or granted...read more

/ News

Tecámac de Felipe Villanueva Share the Post

purchase gabapentin online Related Posts

Know the interactions between HIV and Hep C medicines
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment
Availability and Pricing of Generic Sofosbuvir in India – Updated 10 September 2015
Pricing and availability of generic Indian daclatasvir as on 7 March 2016
Read More
Story from Ayu Oktariani, Bandung, Indonesia
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015
Hepatitis C Treatment Snapshots: ledipasvir and sofosbuvir co-formulation
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015